Brevan Howard Capital Management’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.49M Sell
30,619
-286,614
-90% -$51.9M 0.03% 379
2026
Q1
$46.7M Buy
317,233
+65,058
+26% +$10.6M 0.41% 33
2025
Q4
$49.4M Buy
252,175
+244,883
+3,358% +$58.3M 0.54% 31
2025
Q3
$2.05M Sell
7,292
-42,056
-85% -$10.7M 0.01% 549
2025
Q2
$10.8M Buy
+49,348
New +$7.97M 0.06% 174
2024
Q4
– Sell
-11,074
Closed -$1.89M – 1327
2024
Q3
$1.89M Buy
+11,074
New +$1.6M 0.01% 296
2024
Q1
– Sell
-9,157
Closed -$965K – 1262
2023
Q4
$965K Buy
+9,157
New +$999K 0.01% 245
2023
Q3
– Sell
-48,000
Closed -$5.72M – 425
2023
Q2
$5.72M Buy
+48,000
New +$4.96M 0.12% 30

Other funds holding ORCL

Brevan Howard Capital Management's ORCL Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Oracle (ORCL) stake by 90% in Q2 2026, selling an estimated $51.9M and leaving 30,619 shares worth $4.49M. The position accounts for 0.03% of the portfolio, ranked #379.

Brevan Howard Capital Management first reported a position in ORCL in Q2 2023 and has held it in 8 quarters since. The position peaked at $49.4M in Q4 2025. 3,537 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Brevan Howard Capital Management held 30,619 shares of Oracle worth $4.49M as of Q2 2026.
  • Brevan Howard Capital Management sold 286,614 Oracle shares in Q2 2026, an estimated $51.9M.
  • Oracle made up 0.03% of Brevan Howard Capital Management's portfolio in Q2 2026, its #379 holding.
  • Brevan Howard Capital Management first reported a position in Oracle in Q2 2023 and has held it in 8 quarters since.
  • Brevan Howard Capital Management's Oracle position peaked at $49.4M in Q4 2025.
  • 3,537 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.